Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Preliminary results of a counselling programme for fertility preservation in female cancer patients: The experience of the GEMME DORMIENTI network.

Ciccarone M, Hohaus S, Pulsoni A, Cavaceppi P, Franzò S, Fabbri R, Cudillo L, Battistini R, Di Rocco A, Annibali O, Cox MC, Provenzano I, Abruzzese E, Renzi D, Tesei C, Anticoli Borza P, Cuccaro A, Andriani A, D'Elia GM, Facchiano A, Marchetti P, Cantonetti M.

Eur J Cancer Care (Engl). 2019 Sep 30:e13174. doi: 10.1111/ecc.13174. [Epub ahead of print]

PMID:
31571303
2.

The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network 'Rete Ematologica del Lazio per i Linfomi' (RELLI).

Annibali O, Hohaus S, Marchesi F, Cantonetti M, Di Rocco A, Tomarchio V, Di Napoli A, Pelliccia S, Battistini R, Anticoli Borza P, Abruzzese E, Cenfra N, Andriani A, Tesei C, Alma E, Palombi F, Pupo L, Petrucci L, Becilli M, Maiolo E, Bellesi S, Cuccaro A, D'Alò F, Cox MC.

Leuk Lymphoma. 2019 Jul 1:1-9. doi: 10.1080/10428194.2019.1633628. [Epub ahead of print]

PMID:
31259651
3.

Clinical and Antitumor Immune Responses in Relapsed/Refractory Follicular Lymphoma Patients after Intranodal Injections of IFNα-Dendritic Cells and Rituximab: a Phase I Clinical Trial.

Cox MC, Castiello L, Mattei M, Santodonato L, D'Agostino G, Muraro E, Martorelli D, Lapenta C, Di Napoli A, Di Landro F, Cangemi M, Pavan A, Castaldo P, Hohaus S, Donati S, Montefiore E, Berdini C, Carlei D, Monque DM, Ruco L, Prosperi D, Tafuri A, Spadaro F, Sestili P, Spada M, Dolcetti R, Santini SM, Rozera C, Aricò E, Capone I, Belardelli F.

Clin Cancer Res. 2019 Sep 1;25(17):5231-5241. doi: 10.1158/1078-0432.CCR-19-0709. Epub 2019 Jun 6.

PMID:
31171545
4.

Richter Syndrome Presenting With Colon Localization.

Lavalle M, Minordi LM, Hohaus S, Manfredi R, Rufini V.

Clin Nucl Med. 2019 Feb;44(2):e87-e89. doi: 10.1097/RLU.0000000000002393.

PMID:
30516680
5.

Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death.

Visco C, Tisi MC, Evangelista A, Di Rocco A, Zoellner AK, Zilioli VR, Hohaus S, Sciarra R, Re A, Tecchio C, Chiappella A, Morello L, Gini G, Nassi L, Perrone T, Molinari AL, Fabbri A, Cox MC, Finolezzi E, Ferrero S, Puccini B, Alvarez De Celis I, Arcari A, Marino D, Merli M, Piazza F, Gentile M, Pelosini M, Loseto G, Hermine O, Dreyling M, Ruggeri M, Martelli M, Hoster E, Vitolo U; Fondazione Italiana Linfomi and the Mantle Cell Lymphoma Network.

Br J Haematol. 2019 Jun;185(5):940-944. doi: 10.1111/bjh.15643. Epub 2018 Nov 8. No abstract available.

PMID:
30407625
6.

Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization.

Hohaus S, Tisi MC, Bartolomei F, Cuccaro A, Maiolo E, Alma E, D'Alò F, Bellesi S, Rossi E, De Stefano V.

Blood Cancer J. 2018 Jun 7;8(6):54. doi: 10.1038/s41408-018-0096-1. No abstract available.

7.

FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET).

Annunziata S, Cuccaro A, Tisi MC, Hohaus S, Rufini V.

Ann Nucl Med. 2018 Jun;32(5):372-377. doi: 10.1007/s12149-018-1243-2. Epub 2018 Feb 20.

PMID:
29464479
8.

Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma.

Spina V, Bruscaggin A, Cuccaro A, Martini M, Di Trani M, Forestieri G, Manzoni M, Condoluci A, Arribas A, Terzi-Di-Bergamo L, Locatelli SL, Cupelli E, Ceriani L, Moccia AA, Stathis A, Nassi L, Deambrogi C, Diop F, Guidetti F, Cocomazzi A, Annunziata S, Rufini V, Giordano A, Neri A, Boldorini R, Gerber B, Bertoni F, Ghielmini M, Stüssi G, Santoro A, Cavalli F, Zucca E, Larocca LM, Gaidano G, Hohaus S, Carlo-Stella C, Rossi D.

Blood. 2018 May 31;131(22):2413-2425. doi: 10.1182/blood-2017-11-812073. Epub 2018 Feb 15.

PMID:
29449275
9.

Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy.

Hohaus S, Tisi MC, Bellesi S, Maiolo E, Alma E, Tartaglia G, Corrente F, Cuccaro A, D'Alo' F, Basile U, Larocca LM, De Stefano V.

Cancer Med. 2018 Jan;7(1):270-281. doi: 10.1002/cam4.1166. Epub 2017 Dec 22.

10.

Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients.

Ferretti E, Hohaus S, Di Napoli A, Belmonte B, Cuccaro A, Cupelli E, Galli E, Rufini V, Tripodi G, Fraternali-Orcioni G, Pistoia V, Corcione A.

Oncotarget. 2017 Jul 28;8(49):85263-85275. doi: 10.18632/oncotarget.19665. eCollection 2017 Oct 17.

11.

Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population.

Cingolani A, Cozzi Lepri A, Teofili L, Galli L, Mazzotta V, Baldin GM, Hohaus S, Bandera A, Alba L, Galizzi N, Castagna A, D'arminio Monforte A, Antinori A; ICONA Foundation Study group.

PLoS One. 2017 Oct 31;12(10):e0186549. doi: 10.1371/journal.pone.0186549. eCollection 2017.

12.

Dural MALT Lymphoma Detected by 11C-Methionine PET/CT.

Annunziata S, Cuccaro A, Caldarella C, Hohaus S.

Clin Nucl Med. 2017 Dec;42(12):962-963. doi: 10.1097/RLU.0000000000001843.

PMID:
28902730
13.

11C-Methionine-Avid Plasmablastic Lymphoma.

Annunziata S, Cuccaro A, Caldarella C, Leccisotti L, Hohaus S.

Clin Nucl Med. 2017 Nov;42(11):872-873. doi: 10.1097/RLU.0000000000001803.

PMID:
28825948
14.

Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma.

Broccoli A, Pellegrini C, Di Rocco A, Puccini B, Patti C, Gini G, Mannina D, Tani M, Rusconi C, Romano A, Vanazzi A, Botto B, Carlo-Stella C, Hohaus S, Musto P, Mazza P, Molica S, Corradini P, Fama A, Gaudio F, Merli M, Gravetti A, Gritti G, Arcari A, Tosi P, Liberati AM, Pinto A, Pavone V, Gherlinzoni F, Naso V, Volpetti S, Trentin L, Goldaniga MC, Bonfichi M, De Renzo A, Schiavotto C, Spina M, Storti S, Carella AM, Stefoni V, Argnani L, Zinzani PL.

Haematologica. 2017 Nov;102(11):1931-1935. doi: 10.3324/haematol.2017.171355. Epub 2017 Aug 3.

15.

Heavy chain disease: our experience.

Gulli F, Napodano C, Pocino K, Cuccaro A, Hohaus S, Basile U.

Clin Chem Lab Med. 2017 Nov 27;56(1):e10-e12. doi: 10.1515/cclm-2017-0254. No abstract available.

PMID:
28665788
16.

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy.

Zucca E, Conconi A, Martinelli G, Bouabdallah R, Tucci A, Vitolo U, Martelli M, Pettengell R, Salles G, Sebban C, Guillermo AL, Pinotti G, Devizzi L, Morschhauser F, Tilly H, Torri V, Hohaus S, Ferreri AJM, Zachée P, Bosly A, Haioun C, Stelitano C, Bellei M, Ponzoni M, Moreau A, Jack A, Campo E, Mazzucchelli L, Cavalli F, Johnson P, Thieblemont C.

J Clin Oncol. 2017 Jun 10;35(17):1905-1912. doi: 10.1200/JCO.2016.70.6994. Epub 2017 Mar 29. Erratum in: J Clin Oncol. 2017 Jul 10;35(20):2342.

PMID:
28355112
17.

Clonal evolution in therapy-related neoplasms.

Fabiani E, Falconi G, Fianchi L, Criscuolo M, Ottone T, Cicconi L, Hohaus S, Sica S, Postorino M, Neri A, Lionetti M, Leone G, Lo-Coco F, Voso MT.

Oncotarget. 2017 Feb 14;8(7):12031-12040. doi: 10.18632/oncotarget.14509.

18.

Impaired functional responses in follicular lymphoma CD8+TIM-3+ T lymphocytes following TCR engagement.

Gravelle P, Do C, Franchet C, Mueller S, Oberic L, Ysebaert L, Larocca LM, Hohaus S, Calmels MN, Frenois FX, Kridel R, Gascoyne RD, Laurent G, Brousset P, Valitutti S, Laurent C.

Oncoimmunology. 2016 Aug 24;5(10):e1224044. eCollection 2016.

19.

Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study.

Tisi MC, Hohaus S, Cuccaro A, Innocenti I, De Carolis E, Za T, D'Alò F, Laurenti L, Fianchi L, Sica S, Sanguinetti M, De Stefano V, Pagano L.

Haematologica. 2017 Mar;102(3):e108-e111. doi: 10.3324/haematol.2016.151837. Epub 2016 Nov 17. No abstract available.

20.

Panobinostat for the treatment of acute myelogenous leukemia.

Morabito F, Voso MT, Hohaus S, Gentile M, Vigna E, Recchia AG, Iovino L, Benedetti E, Lo-Coco F, Galimberti S.

Expert Opin Investig Drugs. 2016 Sep;25(9):1117-31. doi: 10.1080/13543784.2016.1216971. Epub 2016 Aug 8. Review.

PMID:
27485472
21.

High-dose therapy for primary CNS lymphoma.

Hohaus S.

Lancet Haematol. 2016 Aug;3(8):e359-60. doi: 10.1016/S2352-3026(16)30060-6. Epub 2016 Jul 13. No abstract available.

PMID:
27476785
22.

Interim FDG-PET/CT in Hodgkin lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET).

Annunziata S, Cuccaro A, Calcagni ML, Hohaus S, Giordano A, Rufini V.

Ann Nucl Med. 2016 Oct;30(8):588-92. doi: 10.1007/s12149-016-1092-9. Epub 2016 May 31.

PMID:
27246952
23.

CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma.

Cuccaro A, Annunziata S, Cupelli E, Martini M, Calcagni ML, Rufini V, Giachelia M, Bartolomei F, Galli E, D'Alò F, Voso MT, Leone G, Giordano A, Larocca LM, Hohaus S.

Cancer Med. 2016 Mar;5(3):398-406. doi: 10.1002/cam4.585. Epub 2016 Jan 13.

24.

Genomic imbalances in circulating DNA in Hodgkin's lymphoma.

Hohaus S.

Lancet Haematol. 2015 Feb;2(2):e48-9. doi: 10.1016/S2352-3026(14)00042-8. Epub 2015 Jan 20. No abstract available.

PMID:
26687607
25.

A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia.

Tisi MC, Giustiniani MC, D'Alò F, Sica S, Hohaus S, Pagano L.

Ann Hematol. 2016 Feb;95(3):517-8. doi: 10.1007/s00277-015-2576-8. Epub 2015 Dec 14. No abstract available.

PMID:
26666534
26.

Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes.

Falconi G, Fabiani E, Fianchi L, Criscuolo M, Raffaelli CS, Bellesi S, Hohaus S, Voso MT, D'Alò F, Leone G.

Exp Hematol. 2016 Jan;44(1):75-83.e1-4. doi: 10.1016/j.exphem.2015.10.005. Epub 2015 Oct 28.

PMID:
26521017
27.

Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma.

Tisi MC, Cupelli E, Santangelo R, Maiolo E, Alma E, Giachelia M, Martini M, Bellesi S, D'Alò F, Voso MT, Pompili M, Leone G, Larocca LM, Hohaus S.

Leuk Lymphoma. 2016;57(3):628-34. doi: 10.3109/10428194.2015.1072766. Epub 2015 Oct 12.

PMID:
26458141
28.

Fanconi anemia gene variants in therapy-related myeloid neoplasms.

Voso MT, Fabiani E, Zang Z, Fianchi L, Falconi G, Padella A, Martini M, Li Zhang S, Santangelo R, Larocca LM, Criscuolo M, La Brocca A, Cutcutache I, Rozen S, Simonetti G, Manfrini M, Martinelli G, Hohaus S, Leone G, Tan P, Tenen DG.

Blood Cancer J. 2015 Jul 3;5:e323. doi: 10.1038/bcj.2015.44. No abstract available.

29.

Safety and efficacy of single-agent bendamustine after failure of brentuximab vedotin in patients with relapsed or refractory hodgkin's lymphoma: experience with 27 patients.

Zinzani PL, Vitolo U, Viviani S, Corradini P, Motta G, Tani M, Cascavilla N, Hohaus S, Merli F, Argnani L, Broccoli A.

Clin Lymphoma Myeloma Leuk. 2015 Jul;15(7):404-8. doi: 10.1016/j.clml.2015.02.023. Epub 2015 Mar 5.

PMID:
25840816
30.

Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma.

Bozzoli V, Tisi MC, Maiolo E, Alma E, Bellesi S, D'Alo' F, Voso MT, Leone G, Hohaus S.

Br J Haematol. 2015 Jun;169(6):787-94. doi: 10.1111/bjh.13358. Epub 2015 Mar 29.

PMID:
25819007
31.

Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication.

Tisi MC, Ausoni G, Vita MG, Tartaglione T, Balducci M, Laurenti L, Chiusolo P, Hohaus S, Sica S.

Mediterr J Hematol Infect Dis. 2015 Mar 1;7(1):e2015025. doi: 10.4084/MJHID.2015.025. eCollection 2015.

32.

Prospective study of hepatitis B virus reactivation in patients with hematological malignancies.

Pompili M, Basso M, Hohaus S, Bosco G, Nosotti L, D'Andrea M, Fenu S, Grieco A, Laurenti L, Mirisola C, Pagano L, Rapaccini GL, Sica S, Storti S, Landolfi R.

Ann Hepatol. 2015 Mar-Apr;14(2):168-74.

33.

Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias.

Fianchi L, Pagano L, Piciocchi A, Candoni A, Gaidano G, Breccia M, Criscuolo M, Specchia G, Maria Pogliani E, Maurillo L, Aloe-Spiriti MA, Mecucci C, Niscola P, Rossetti E, Mansueto G, Rondoni M, Fozza C, Invernizzi R, Spadea A, Fenu S, Buda G, Gobbi M, Fabiani E, Sica S, Hohaus S, Leone G, Voso MT.

Am J Hematol. 2015 May;90(5):E80-5. doi: 10.1002/ajh.23966. Epub 2015 Mar 3.

34.

Primary multifocal lymphoma of peripheral nervous system: case report and review of the literature.

Del Grande A, Sabatelli M, Luigetti M, Conte A, Granata G, Rufini V, Del Ciello A, Gaudino S, Fernandez E, Hohaus S, Coli A, Lauriola L.

Muscle Nerve. 2014 Dec;50(6):1016-22. doi: 10.1002/mus.24354. Epub 2014 Oct 30. Review.

PMID:
25088432
35.

Prognostic factors in hodgkin lymphoma.

Cuccaro A, Bartolomei F, Cupelli E, Galli E, Giachelia M, Hohaus S.

Mediterr J Hematol Infect Dis. 2014 Jul 5;6(1):e2014053. doi: 10.4084/MJHID.2014.053. eCollection 2014. Review.

36.

Quantification of DAPK1 promoter methylation in bone marrow and peripheral blood as a follicular lymphoma biomarker.

Giachelia M, Bozzoli V, D'Alò F, Tisi MC, Massini G, Maiolo E, Guidi F, Cupelli E, Martini M, Larocca LM, Voso MT, Leone G, Hohaus S.

J Mol Diagn. 2014 Jul;16(4):467-76. doi: 10.1016/j.jmoldx.2014.03.003. Epub 2014 May 9.

PMID:
24814955
37.

Why methylation is not a marker predictive of response to hypomethylating agents.

Voso MT, Santini V, Fabiani E, Fianchi L, Criscuolo M, Falconi G, Guidi F, Hohaus S, Leone G.

Haematologica. 2014 Apr;99(4):613-9. doi: 10.3324/haematol.2013.099549. Review.

38.

Methylenetetrahydrofolate reductase polymorphisms in myelodysplastic syndromes and therapy-related myeloid neoplasms.

Criscuolo M, Chiusolo P, Giammarco S, Giachelia M, Fianchi L, Fabiani E, Falconi G, Hohaus S, Sica S, Leone G, Voso MT.

Leuk Lymphoma. 2014 Dec;55(12):2942-4. doi: 10.3109/10428194.2014.903475. Epub 2014 Apr 22. No abstract available.

PMID:
24625325
39.

Bendamustine for Hodgkin lymphoma patients failing autologous or autologous and allogeneic stem cell transplantation: a retrospective study of the Fondazione Italiana Linfomi.

Anastasia A, Carlo-Stella C, Corradini P, Salvi F, Rusconi C, Pulsoni A, Hohaus S, Pregno P, Viviani S, Brusamolino E, Luminari S, Giordano L, Santoro A.

Br J Haematol. 2014 Jul;166(1):140-2. doi: 10.1111/bjh.12821. Epub 2014 Mar 7. No abstract available.

PMID:
24606548
40.

Burkitt's lymphoma of the breast metastatic to the ovary diagnosed during pregnancy.

Testa AC, De Blasis I, Di Legge A, Belli P, Hohaus S, Ferrandina G.

Ultrasound Obstet Gynecol. 2013 Sep;42(3):364-6. No abstract available.

PMID:
24137791
41.

The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes.

Fabiani E, Fianchi L, Falconi G, Boncompagni R, Criscuolo M, Guidi F, La Brocca A, Hohaus S, Leone G, Voso MT.

Leuk Lymphoma. 2014 Jul;55(7):1538-43. doi: 10.3109/10428194.2013.845885. Epub 2013 Nov 1.

PMID:
24047476
42.

Iron in Hodgkin's lymphoma.

Hohaus S, Giachelia M, Cuccaro A, Voso MT, Leone G.

Crit Rev Oncog. 2013;18(5):463-9. Review.

PMID:
23879590
43.

Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin.

Tisi MC, Bozzoli V, Giachelia M, Massini G, Ricerca BM, Maiolo E, D'Alo' F, Larocca LM, Piciocchi A, Tjalsma H, Swinkels DW, Voso MT, Leone G, Hohaus S.

Leuk Lymphoma. 2014 Feb;55(2):270-5. doi: 10.3109/10428194.2013.802314. Epub 2013 Jun 12.

PMID:
23647063
44.

Mantle cell lymphoma relapsing at the lymphedematous arm.

Massini G, Hohaus S, D'Alò F, Bozzoli V, Vannata B, Larocca LM, Teofili L.

Mediterr J Hematol Infect Dis. 2013;5(1):e2013016. doi: 10.4084/MJHID.2013.016. Epub 2013 Feb 16.

45.

Clinical and prognostic features of lymphomas arising in the head and neck region: Our experience of preferential association of different histotypes with various sites of origin in ninety patients.

Bussu F, Hohaus S, Bastanza G, Bozzoli V, Tisi MC, Martini M, Paludetti G, Almadori G.

Clin Otolaryngol. 2013 Jun;38(3):248-53. doi: 10.1111/coa.12090. No abstract available.

PMID:
23374252
46.

Newly proposed therapy-related myelodysplastic syndrome prognostic score predicts significant differences in overall survival and leukemia-free survival in patients treated with azacitidine.

Breccia M, Fianchi L, Lunghi M, Gaidano G, Levis A, Finelli C, Santini V, Musto P, Mansueto G, Oliva EN, Leoni P, Spiriti MA, Hohaus S, Leone G, Alimena G, Voso MT.

Leuk Lymphoma. 2013 Aug;54(8):1786-7. doi: 10.3109/10428194.2012.749406. Epub 2012 Dec 10. No abstract available.

PMID:
23151268
47.

Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases.

Voso MT, Fabiani E, Fianchi L, Falconi G, Criscuolo M, Santangelo R, Chiusolo P, Betti S, D'Alo' F, Hohaus S, De Stefano V, Leone G.

Leukemia. 2013 Apr;27(4):982-5. doi: 10.1038/leu.2012.267. Epub 2012 Sep 11. No abstract available.

PMID:
22964944
48.

High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study.

Fianchi L, Criscuolo M, Breccia M, Maurillo L, Salvi F, Musto P, Mansueto G, Gaidano G, Finelli C, Aloe-Spiriti A, Santini V, Greco M, Hohaus S, Leone G, Voso MT.

Leuk Lymphoma. 2013 Mar;54(3):658-61. doi: 10.3109/10428194.2012.719617. Epub 2012 Aug 30. No abstract available.

PMID:
22873829
49.

Outcome of therapy-related myeloid neoplasms treated with azacitidine.

Fianchi L, Criscuolo M, Lunghi M, Gaidano G, Breccia M, Levis A, Finelli C, Santini V, Musto P, Oliva EN, Leoni P, Aloe Spiriti A, D'Alò F, Hohaus S, Pagano L, Leone G, Voso MT.

J Hematol Oncol. 2012 Aug 1;5:44. doi: 10.1186/1756-8722-5-44.

50.

Prognostic role of gender in diffuse large B-cell lymphoma treated with rituximab containing regimens: a Fondazione Italiana Linfomi/Grupo de Estudos em Moléstias Onco-Hematológicas retrospective study.

Carella AM, de Souza CA, Luminari S, Marcheselli L, Chiappella A, di Rocco A, Cesaretti M, Rossi A, Rigacci L, Gaidano G, Merli F, Spina M, Stelitano C, Hohaus S, Barbui A, Puccini B, Miranda EC, Guida A, Federico M.

Leuk Lymphoma. 2013 Jan;54(1):53-7. doi: 10.3109/10428194.2012.691482. Epub 2012 Sep 28.

PMID:
22712840

Supplemental Content

Loading ...
Support Center